HealthEquity (NASDAQ:HQY) Upgraded at Raymond James

HealthEquity (NASDAQ:HQY) was upgraded by equities researchers at Raymond James from an “outperform” rating to a “strong-buy” rating in a report released on Tuesday,Benzinga reports. The brokerage currently has a $115.00 price objective on the stock, down from their previous price objective of $120.00. Raymond James’ price objective would suggest a potential upside of 27.33% from the stock’s previous close.

HQY has been the subject of a number of other reports. JMP Securities lifted their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. Wells Fargo & Company upped their price target on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. KeyCorp cut their price objective on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Monday. Mizuho began coverage on HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price on the stock. Finally, Barrington Research reissued an “outperform” rating and set a $112.00 price target on shares of HealthEquity in a report on Friday, March 14th. One equities research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, HealthEquity has an average rating of “Buy” and a consensus price target of $113.31.

HealthEquity Stock Performance

Shares of NASDAQ HQY opened at $90.32 on Tuesday. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $7.81 billion, a P/E ratio of 82.86, a P/E/G ratio of 1.60 and a beta of 0.62. HealthEquity has a 12 month low of $65.01 and a 12 month high of $115.59. The stock has a 50 day moving average of $104.67 and a 200-day moving average of $95.84.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.20% of the company’s stock.

Institutional Trading of HealthEquity

Several large investors have recently bought and sold shares of HQY. Intech Investment Management LLC boosted its stake in shares of HealthEquity by 59.5% in the 3rd quarter. Intech Investment Management LLC now owns 21,064 shares of the company’s stock valued at $1,724,000 after purchasing an additional 7,859 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in HealthEquity by 1.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,061,807 shares of the company’s stock valued at $86,909,000 after purchasing an additional 14,532 shares during the last quarter. Raymond James Trust N.A. boosted its position in HealthEquity by 4.8% in the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after buying an additional 132 shares in the last quarter. Citigroup Inc. grew its stake in shares of HealthEquity by 73.0% during the third quarter. Citigroup Inc. now owns 102,107 shares of the company’s stock worth $8,357,000 after buying an additional 43,084 shares during the last quarter. Finally, Cerity Partners LLC grew its stake in shares of HealthEquity by 15.1% during the third quarter. Cerity Partners LLC now owns 17,259 shares of the company’s stock worth $1,413,000 after buying an additional 2,258 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.